-
Taylor sparks Colts to Berlin win as Pats streak hits seven
-
Dreyer, Pellegrino lift San Diego to 4-0 MLS Cup playoff win over Portland
-
Indonesia names late dictator Suharto a national hero
-
Fourth New Zealand-West Indies T20 washed out
-
Tanzania Maasai fear VW 'greenwashing' carbon credit scheme
-
Chinese businesswoman faces jail after huge UK crypto seizure
-
Markets boosted by hopes for deal to end US shutdown
-
Amazon poised to host toughest climate talks in years
-
Ex-jihadist Syrian president due at White House for landmark talks
-
Saudi belly dancers break taboos behind closed doors
-
The AI revolution has a power problem
-
Big lips and botox: In Trump's world, fashion and makeup get political
-
NBA champion Thunder rally to down Grizzlies
-
US senators reach deal that could end record shutdown
-
Weakening Typhoon Fung-wong exits Philippines after displacing 1.4 million
-
Lenny Wilkens, Basketball Hall of Famer as player and coach, dies
-
Griffin wins PGA Mexico title for third victory of the year
-
NFL makes successful return to Berlin, 35 years on
-
Lewandowski hat-trick helps Barca punish Real Madrid slip
-
George warns England against being overawed by the All Blacks
-
Lewandowski treble helps Barca beat Celta, cut gap on Real Madrid
-
Neves late show sends PSG top of Ligue 1, Strasbourg down Lille
-
Inter go top of Serie A after Napoli slip-up
-
Bezos's Blue Origin postpones rocket launch over weather
-
Hamilton upbeat despite 'nightmare' at Ferrari
-
Taylor sparks Colts to Berlin win, Pats win streak hits seven
-
Alcaraz and Zverev make winning starts at ATP Finals
-
Protests suspend opening of Nigeria heritage museum
-
Undav brace sends Stuttgart fourth, Frankfurt win late in Bundesliga
-
Roma capitalise on Napoli slip-up to claim Serie A lead
-
Liverpool up for the fight despite Man City masterclass, says Van Dijk
-
Two MLB pitchers indicted on manipulating bets on pitches
-
Wales rugby captain Morgan set to be sidelined by shoulder injury
-
After storming Sao Paulo podium, 'proud' Verstappen aims to keep fighting
-
US flights could 'slow to a trickle' as shutdown bites: transport secretary
-
Celtic close on stumbling Scottish leaders Hearts
-
BBC chief resigns after row over Trump documentary
-
Norris extends title lead in Sao Paulo, Verstappen third from pit-lane
-
Norris wins in Sao Paulo to extend title lead over Piastri
-
Man City rout Liverpool to mark Guardiola milestone, Forest boost survival bid
-
Man City crush Liverpool to mark Guardiola's 1,000 match
-
Emegha fires Strasbourg past Lille in Ligue 1
-
Howe takes blame for Newcastle's travel sickness
-
Pumas maul Wales as Tandy's first game in charge ends in defeat
-
'Predator: Badlands' conquers N. American box office
-
Liga leaders Real Madrid drop points in Rayo draw
-
'Killed on sight': Sudanese fleeing El-Fasher recall ethnic attacks
-
Forest boost survival bid, Man City set for crucial Liverpool clash
-
US air travel could 'slow to a trickle' as shutdown bites: transport secretary
-
Alcaraz makes winning start to ATP Finals
Featured
Last news
PLDT Goes Live with the Amdocs Customer Engagement Platform to Redefine Customer Experiences
The cloud-native, AI-enabled Amdocs platform, in collaboration with Microsoft, modernizes PLDT's customer service, enabling faster service rollouts, end-to-end case management, and real-time network-to-service integration
A1 Bulgaria Successfully Completes Major Platform Upgrade with Amdocs to Improve Customer Experience
Convergent charging platform upgrade is the final stage in the Bulgarian operator's platform modernization program, providing end users with faster response times, greater billing transparency, and improved service reliability
Japan's NTT InfraNet Successfully Deploys Advanced, Cloud-Native Platform, and Migrates Workloads with Amdocs
By modernizing and migrating its IT operations systems to the cloud, NTT InfraNet will now be able to introduce innovative services across multiple divisions and support their business ambitions
CKH Innovations Opportunities Development Selects Amdocs MarketONE to Enhance its Telco Group's Digital Service Offerings
By addressing key challenges such as partner management, subscription fatigue, and customer retention, Amdocs MarketONE equips participating CK Hutchison telco companies to grow their digital ecosystem and capture new revenue streams, while delivering enhanced experiences to their customers
Singapore's M1 Collaborates with Amdocs to Manage Newly Delivered Cloud-Native Charging Platform
The agreement will foster growth, enhance operational efficiency, and empower M1 to deliver consistent, high-quality end-user experiences
T-Mobile Czech Republic Completes Billing & Charging System Upgrade with Amdocs
Completion of this upgrade ensures seamless service continuity and operational efficiency, enhancing customer experience by enabling faster, more agile, and reliable service delivery
CSPi to Announce Fiscal Second Quarter Results on May 14, 2025
LOWELL, MA / ACCESS Newswire / May 7, 2025 / CSPi (NASDAQ:CSPI), an award-winning provider of security and packet capture products, managed IT and professional services and technology solutions, announced that it will issue its fiscal 2025 second quarter financial results before the open of the market on Wednesday May 14, 2025.
SpaceX gets US approval to launch more Starship flights from Texas
Elon Musk's SpaceX on Tuesday received approval from the US Federal Aviation Administration (FAA) to increase the number of annual Starship rocket launches from five to 25 at its Texas base, marking a major boost for the company's ambitions.
ACCESS Newswire to Host First Quarter Earnings Conference Call on May 13, 2025
RALEIGH, NC / ACCESS Newswire / May 6, 2025 / ACCESS Newswire Inc. (NYSE American:ACCS), an industry-leading communications company, today announced it will host a conference call and live webcast on May 13, 2025, at 9:00am Eastern Time to discuss the results of the first quarter 2025.
OMP Achieves Top Two Rankings in Four Use Cases in the 2025 Gartner Critical Capabilities for Supply Chain Planning Solutions Report
ANTWERPEN, BE / ACCESS Newswire / May 6, 2025 / OMP, a global leader in supply chain planning solutions, has achieved four second-highest scores across five Use Cases, evaluated in the 2025 Gartner® Critical Capabilities for Supply Chain Planning Solutions report. This report, a companion to the Gartner Magic Quadrant™, assesses the vendors of the SCP solutions evaluated in this research.
Ryde Reaffirms Commitment to Gig Workers at NTUC May Day Rally, Supporting Inclusive Growth and Fair Work Practices
SINGAPORE, SINGAPORE / ACCESS Newswire / May 6, 2025 / Ryde Group Ltd (NYSE American:RYDE) ("Ryde'' or the "Company"), a technology company with a leading platform for mobility and quick commerce in Singapore, proudly reaffirmed its commitment to gig workers at the NTUC May Day Rally 2025, joining over 1,600 union leaders, tripartite partners, and fellow Singaporeans in support of a more inclusive, resilient workforce.
Netlist Reports First Quarter 2025 Results
IRVINE, CA / ACCESS Newswire / May 6, 2025 / Netlist, Inc. (OTCQB:NLST) today reported financial results for the first quarter ended March 29, 2025.
Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
BRIDGEWATER, NEW JERSEY / ACCESS Newswire / May 6, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology released pharmacokinetic and metabolism data from its Phase 1 study of TH104, a buccal film formulation of nalmefene, in healthy subjects. Tharimmune recently highlighted the advancement of TH104 for the proposed indication of temporary prophylaxis against respiratory and/or central nervous system depression in military personnel and chemical incident responders exposed to high-potency opioids, following recent positive feedback from the U.S. Food and Drug Administration (FDA).
Eden Radioisotopes and Cross River Infrastructure Partners Sign MOU to Explore Development of a New Generation Medical Radioisotope Reactor in New Brunswick
ALBUQUERQUE, NM AND GREENWICH, CT / ACCESS Newswire / May 6, 2025 / Eden Radioisotopes, LLC ("Eden") and Cross River Infrastructure Partners, LLC ("CRIP") are pleased to announce the execution of a Memorandum of Understanding (MOU) to jointly explore the development of a new nuclear medical radioisotope reactor and hot cell processing facility in the Province of New Brunswick, Canada. This collaboration marks a significant step forward in Canada's efforts to expand its capabilities in nuclear medicine and build a resilient, regionally anchored supply chain for lifesaving radiodiagnostics and radiopharmaceuticals to bolster regional and national healthcare sovereignty by enabling a secure and sustainable supply of critical medical radioisotopes.
Upexi Increases Solana Treasury to 201,500 Solana Tokens for $30 Million and Begins to Generate Staking Revenue
Company has over $60 million in cash remaining to invest further in SOLAt current price of SOL and staking yield, Upexi expects to receive approximately $2.4 million in annual staking revenue and $7.0 million once all funds are invested and staked
Avant Technologies and Partner, Ainnova, Receive FDA Pre-Submission Meeting Date for Company’s Vision AI Platform Technology
LAS VEGAS, NEVADA / ACCESS Newswire / May 6, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that the U.S. Food and Drug Administration (FDA) has scheduled its pre-submission meeting with Ainnova's executives and its CRO, Fortrea, for July 7, 2025, to discuss a range of items related to the Company's planned clinical trial of its Vision AI platform in the early detection of diabetic retinopathy.
Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order
Thrive in 2025 by Tony Robbins and Dean Graziosi: What It Is, When It Happens, and Who It's For (Guide Released)
IRAEmpire.com has published a detailed review and update on the Thrive in 2025 event for consumers.
Movella Holdings Inc. Announces Completion of Corporate Restructuring
LOS ANGELES, CA / ACCESS Newswire / May 6, 2025 / Movella Holdings Inc. (the "Company") today announced the completion of a restructuring transaction involving its wholly-owned subsidiary, Movella Inc. ("Movella"), and its existing secured lenders.
Greenlite Announces Pre-Launch of NLCSwap a Fully U.S. Compliant Decentralized DEX Crypto Exchange
LOS ANGELES, CALIFORNIA / ACCESS Newswire / May 6, 2025 / Greenlite Ventures, Inc. is proud to announce the pre-launch of NLCSwap.com starting in Montana, a revolutionary decentralized cryptocurrency exchange that combines the best of both worlds: the autonomy and security of a decentralized exchange (DEX) with full compliance under U.S. regulations, including FinCEN registration and strict adherence to KYC (Know Your Customer) and AML (Anti-Money Laundering) protocols.
Crexendo Announces Strong First Quarter 2025 Results
PHOENIX, AZ / ACCESS Newswire / May 6, 2025 / Crexendo, Inc. (NASDAQ:CXDO), an award-winning software technology company that is a premier provider of cloud communication platform and services, video collaboration and managed IT services tailored to businesses of all sizes, today announced financial results for the first quarter ended March 31, 2025.
eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health
N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity.eXoZymes used its AI-driven development platform to progress from idea to purpose-built subsidiary in less than 3 months and at a fraction of normal SynBio R&D cost.NCTx is scaling up an exozyme biosolution to overcome a longstanding bottleneck in sourcing the NCT compound from nature, where it occurs only in trace amounts.Interesting pre-clinical data point towards Non-Alcoholic Fatty Liver Disease (NAFLD) that affects more than 30% of the global population.Only NCTx can make both the natural product NCT, and a range of very interesting new-to-nature analog versions, expanding the pharma potential.NCT is the first of more "powered by eXoZymes" natural product nutraceuticals, that also have the potential to become pharmaceuticals.
Loar Holdings Inc. Announces Date and Time for First Quarter 2025 Earnings Conference Call
WHITE PLAINS, NY / ACCESS Newswire / May 6, 2025 / Loar Holdings Inc. (NYSE:LOAR), will report Q1 2025 earnings before the market opens on Tuesday, May 13, 2025.
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
Nazi surrender site sets the scene for Wim Wenders short film
Award-winning German director Wim Wenders has revisited the French school where Nazi Germany signed its initial 1945 surrender for a short film released Monday, days before Europe marks 80 years since the end of World War II.
France, EU leaders spearhead effort to lure US scientists
French President Emmanuel Macron and European Commission head Ursula von der Leyen were set on Monday to host a conference in Paris aimed at attracting US researchers ready to relocate because of President Donald Trump's policies.
Inovatec Portal Selected as Finalist for Banking Tech Awards USA
Innovative Loan Application Processing Solution is Shortlisted in the "Best Auto and Equipment LendTech" Category
C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
KALAMAZOO, MI / ACCESS Newswire / May 5, 2025 / C2Dx, a leading medical device company known for acquiring and revitalizing essential, underserved technologies, is proud to announce its rebrand to Everis. This transformation reflects the company's continued commitment to elevating possibilities in healthcare, expanding its focus, and propelling impactful surgical technologies forward.
C2 Blockchain Inc. Launches AI-Powered Crypto Chatbot in Beta, Pioneering New Subscription Revenue Model and Advancing Toward Market Leadership in Web3 Intelligence
MIAMI BEACH, FL / ACCESS Newswire / May 5, 2025 / C2 Blockchain Inc. (OTC PINK:CBLO), a forward-thinking blockchain infrastructure and digital asset strategy company, proudly announces the beta launch of its proprietary AI-powered crypto chatbot - a powerful trading assistant aimed at transforming how individuals and institutions engage with the crypto markets. With this launch, the company not only deepens its technological footprint but also introduces a scalable, recurring subscription-based revenue stream.
WanAware Exposes Telecom Industry Blindspots In 2025 Observability Benchmark Report
New data reveals telecom's observability gap and its rising toll on performance, security, and AI readiness.
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks
Global Interactive Technologies, Inc. Receives Compliance Notice from Nasdaq
SEOUL, KOREA / ACCESS Newswire / May 5, 2025 / Global Interactive Technologies, Inc. (NASDAQ:GITS) (the "Company"), announced that on April 30, 2025 the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, based on the April 30, 2025 filing of the Company's Form 10-K for the year ended December 31, 2024, the Company is now in compliance with Nasdaq's listing requirements.